Skip to main content
Smart Investors Daily
AP

NYSE · APO

Apollo Global Management, Inc.

Financial Services · Asset Management - Global

$122.74

Up+$2.06 (+1.68%)

Updated Nov 11, 2026, 4:02 PM

SID Score

6.9/10

Composite research score

Smart Money

58/100

Neutral

Market cap
60.71B
P/E ratio
14.19
Dividend yield
1.62%
52-week range
$99.56 – $146.25
Volume
3.01M
Avg. volume
3.6M

Price performance · APO

APO price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 10, 2026

APO closed at $122.74 after 21 trading sessions, up 5.56% for the selected period.

Last close
$122.74
Period change
+5.56%
Period low
$110.78
Period high
$122.76
Daily close
View OHLC price history
APO OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 10, 2026$122.76$123.30$121.37$122.743.01M
Nov 9, 2026$119.01$123.74$117.77$122.203M
Nov 6, 2026$117.44$118.785$115.65$116.753.32M
Nov 5, 2026$124.32$125.43$114.855$117.276.04M
Nov 4, 2026$116.87$123.08$116.12$122.767.57M
Nov 3, 2026$117.16$117.52$112.01$113.556.25M
Nov 2, 2026$117.41$122.58$116.92$119.465.23M
Oct 30, 2026$118.43$118.49$115.37$115.845.28M
Oct 29, 2026$115.40$118.72$114.66$118.563.33M
Oct 28, 2026$114.09$114.785$112.40$113.453.79M
Oct 27, 2026$115.68$116.47$114.155$114.262.34M
Oct 26, 2026$114.02$117.16$114.00$114.372.85M
Oct 23, 2026$113.44$114.20$111.98$112.832.78M
Oct 22, 2026$109.99$114.86$109.91$114.834.21M
Oct 21, 2026$112.66$113.01$110.97$111.694.12M
Oct 20, 2026$110.71$113.64$110.34$111.222.29M
Oct 19, 2026$113.00$114.16$110.57$110.952.34M
Oct 16, 2026$112.84$115.92$110.74$110.784.08M
Oct 15, 2026$113.50$114.095$110.28$111.877.21M
Oct 14, 2026$115.90$116.65$111.41$113.394.65M
Oct 13, 2026$120.02$120.02$115.20$116.283.89M

Latest APO news

The latest Smart Investors Daily articles mentioning APO.

APO research

Overview

Company profile and research snapshot.

Company profile

Apollo is one of the world's largest alternative asset managers, with $908.4 billion in total assets under management, or AUM, including $685.0 billion in fee-earning assets, at the end of September 2025. The company has two core operating segments: asset management and retirement services. Apollo operates with scale in each of its major product lines-private equity (with $125.6 billion in total AUM and $71.7 billion in fee-earning AUM), real estate/real assets ($59.6 billion/$27.1 billion), and private credit ($723.2 billion/$586.2 billion). Apollo has a distribution profile that is likely not too far off from the industry averages-with 84% of its assets held by institutional investors and 16% by high-net-worth clients.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$159.00
Implied upside
—
Analysts
14
APO recent ratings
DateFirmRatingTarget
Nov 6, 2026Argus ResearchBuy—
Nov 5, 2026UBSBuy—
Nov 4, 2026RBC CapitalSector Perform—
Nov 4, 2026BarclaysOverweight—
Nov 4, 2026Morgan StanleyOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 7, 2026

Apollo Global Management (APO) Stock Looks Below Fair Value After Record Origination

Apollo Global Management has delivered a 71.5% total return over the past 5 years, yet the current share price near US$116.75 raises a simple question for you as an investor. Are you paying a fair price for what the business actually earns on the capital it puts to work? A 71.5% gain over 5 years means long term holders have already seen a lot of value created, so the issue now is whether future returns on Apollo Global Management’s capital can support the current valuation. Record asset...

Yahoo · Nov 6, 2026

Apollo-backed dental firm vVardis seeks up to $229 million in US IPO

Investing.com -- Swiss dental technology startup vVardis Holding AG is seeking to raise up to $228.6 million in an initial public offering on the New York Stock Exchange, targeting a fully diluted valuation of roughly $4.4 billion at the top of its marketed range. The Zug-based company, backed by Apollo Global Management and OrbiMed Advisors, is offering 9,523,810 Class A ordinary shares priced between $21.00 and $24.00 apiece, according to its prospectus filed with the U.S. Securities and Excha

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.